PT1095143E - Inibidor para o diagnóstico e tratamento de doentes com hemofilia a - Google Patents

Inibidor para o diagnóstico e tratamento de doentes com hemofilia a Download PDF

Info

Publication number
PT1095143E
PT1095143E PT99921292T PT99921292T PT1095143E PT 1095143 E PT1095143 E PT 1095143E PT 99921292 T PT99921292 T PT 99921292T PT 99921292 T PT99921292 T PT 99921292T PT 1095143 E PT1095143 E PT 1095143E
Authority
PT
Portugal
Prior art keywords
factor viii
human antibody
antibody
specificity
nucleotide sequence
Prior art date
Application number
PT99921292T
Other languages
English (en)
Inventor
Johannes Jacobus Voorberg
Edward Norbert Van Den Brink
Ellen Anne Maria Turenhout
Original Assignee
Sanquin Bloedvoorziening
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanquin Bloedvoorziening filed Critical Sanquin Bloedvoorziening
Publication of PT1095143E publication Critical patent/PT1095143E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring Temperature Or Quantity Of Heat (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT99921292T 1998-05-08 1999-05-07 Inibidor para o diagnóstico e tratamento de doentes com hemofilia a PT1095143E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98201543 1998-05-08

Publications (1)

Publication Number Publication Date
PT1095143E true PT1095143E (pt) 2008-11-28

Family

ID=8233706

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99921292T PT1095143E (pt) 1998-05-08 1999-05-07 Inibidor para o diagnóstico e tratamento de doentes com hemofilia a

Country Status (12)

Country Link
US (1) US7364735B1 (pt)
EP (1) EP1095143B1 (pt)
JP (1) JP2002514422A (pt)
AT (1) ATE405649T1 (pt)
AU (1) AU760678B2 (pt)
CA (1) CA2327587C (pt)
CY (1) CY1108568T1 (pt)
DE (1) DE69939379D1 (pt)
DK (1) DK1095143T3 (pt)
ES (1) ES2313783T3 (pt)
PT (1) PT1095143E (pt)
WO (1) WO1999058680A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197526B1 (en) * 1999-01-04 2001-03-06 Dyax Corp. Polypeptides for binding human factor VIII and fragments of human factor VIII
US7112438B2 (en) 1999-01-04 2006-09-26 Dyax Corp. Binding molecules for human factor VIII and factor VIII-like proteins
US7829085B2 (en) 1999-07-14 2010-11-09 Life Sciences Research Partners Vzw Methods of treating hemostasis disorders using antibodies binding the C1 domain of factor VIII
EP1325342A2 (en) * 2000-10-13 2003-07-09 Baxter Aktiengesellschaft Xenogeneic antibody containing plasma reagents and associated methods
DE60332011D1 (de) * 2002-04-29 2010-05-20 Sanquin Bloedvoorziening Antagonisten der interaktion zwischen faktor viii und lrp ("low-density lipoprotein receptor related protein")
EP1388544A1 (en) 2002-07-31 2004-02-11 D. Collen Research Foundation vzw Anti-idiotypic antibodies against factor VIII inhibitor and uses thereof
CA2535489C (en) 2003-08-14 2014-09-30 D. Collen Research Foundation Vzw Antibodies against factor viii with modified glycosylation in the variable region
FR2889534B1 (fr) * 2005-08-04 2012-11-02 Lab Francais Du Fractionnement Anticorps anti-idiotypique neutralisant l'activite inhibitrice d'un anticorps inhibiteur du facteur viii
CN110382547B (zh) * 2016-12-14 2023-06-06 盼展生物技术有限公司 抗凝血因子viii抗体及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731245A (en) * 1983-12-29 1988-03-15 Kitasato Kenkyusho Vaccine, antigen and antibody for treating microorganisms of the MCLS-type streptococcus sanguis
EP0152746B1 (en) 1984-01-12 1991-08-14 Chiron Corporation Hybridoma cell lines and monoclonal antibodies to factor viiic
US5543145A (en) * 1984-09-17 1996-08-06 Baxter International, Inc. Pharmaceutical composition and method for the suppression of factor VIII inhibitor production
US5149637A (en) * 1987-04-06 1992-09-22 Scripps Clinic & Research Foundation Recombinant Factor VIIIC fragments
US5859205A (en) * 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
WO1993003151A1 (en) 1991-08-10 1993-02-18 Medical Research Council Treatment of cell populations
WO1993012232A1 (en) * 1991-12-10 1993-06-24 Dana Farber Cancer Institute Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof
AU7732894A (en) * 1993-09-22 1995-04-10 Nichols Institute Diagnostics Graves' ophthalmopathy associated antibodies, graves' ophthalmopathy orbital antigen, and methods of use thereof
EP0659766A1 (en) 1993-11-23 1995-06-28 Schering-Plough Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
WO1996005860A1 (en) * 1994-08-19 1996-02-29 Novo Nordisk A/S A method of treating a patient with a biologically active compound
US6258529B1 (en) * 1994-12-01 2001-07-10 Oravax, Inc. PCR amplification of rearranged genomic variable regions of immunoglobulin genes
MA24512A1 (fr) * 1996-01-17 1998-12-31 Univ Vermont And State Agrienl Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose
US5916771A (en) * 1996-10-11 1999-06-29 Abgenix, Inc. Production of a multimeric protein by cell fusion method

Also Published As

Publication number Publication date
CA2327587C (en) 2011-09-13
EP1095143B1 (en) 2008-08-20
WO1999058680A2 (en) 1999-11-18
DE69939379D1 (de) 2008-10-02
US7364735B1 (en) 2008-04-29
CA2327587A1 (en) 1999-11-18
ATE405649T1 (de) 2008-09-15
AU3853899A (en) 1999-11-29
CY1108568T1 (el) 2014-04-09
EP1095143A2 (en) 2001-05-02
JP2002514422A (ja) 2002-05-21
DK1095143T3 (da) 2009-01-05
ES2313783T3 (es) 2009-03-01
AU760678B2 (en) 2003-05-22
WO1999058680A3 (en) 2001-02-22

Similar Documents

Publication Publication Date Title
CY1108568T1 (el) Αναστολεας για διαγνωση και θεραπεια ασθενων με αιμορροφιλια α
EP2270041A3 (en) KDR peptides and vaccines comprising the same
DE69738581D1 (de) Menschliche dnase i hyperaktive varianten
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
EP1005540A4 (en) IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS
WO1998006841A3 (en) Two human nsp-like proteins
DE69816467D1 (de) Robo: eine familie polypeptiden und nukleinesäuren wirksam in nervenzellleitung
ATE356145T1 (de) Polypeptide zur regenerierung des nervensystems
ATE325812T1 (de) Menschliches, gebärmutterkrebs-spezifisches suppressorprotein, für das protein kodieres polynukleotid, mit dem polynukleotid transformierte zelle und verfahren zur unterdrückung der proliferation von krebszellen unter verwendung des expressionsvektors
NO973876L (no) Human-DNase I-varianter
ATE375390T1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
WO1998012220A3 (en) Novel tumor proteins
EP1244692A4 (en) COMPOSITIONS AND METHOD FOR DETECTING STRESS-INDUCED PROTEINS
WO2004003010A3 (en) Nuclear hormone receptor ligano-binding domain containing protein
MX9806628A (es) Gen de respuesta de diferenciacion terminal mieloide humana novedoso.
DK1158050T3 (da) Human cysteinyl-leukotrienreceptor (CysLT2)